Kelly K - Search Results

1

Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity.

Abou-Kheir W, Hynes PG, Martin P, Yin JJ, Liu YN, Seng V, Lake R, Spurrier J, Kelly K. Abou-Kheir W, et al. Among authors: kelly k. PLoS One. 2011;6(10):e26112. doi: 10.1371/journal.pone.0026112. Epub 2011 Oct 11. PLoS One. 2011. PMID: 22022528 Free PMC article.

2

TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation.

Casey OM, Fang L, Hynes PG, Abou-Kheir WG, Martin PL, Tillman HS, Petrovics G, Awwad HO, Ward Y, Lake R, Zhang L, Kelly K. Casey OM, et al. Among authors: kelly k. PLoS One. 2012;7(7):e41668. doi: 10.1371/journal.pone.0041668. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22860005 Free PMC article.

3

Prostate cancer and metastasis initiating stem cells.

Kelly K, Yin JJ. Kelly K, et al. Cell Res. 2008 May;18(5):528-37. doi: 10.1038/cr.2008.50. Cell Res. 2008. PMID: 18414448 Review.

4

Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model.

Abou-Kheir WG, Hynes PG, Martin PL, Pierce R, Kelly K. Abou-Kheir WG, et al. Among authors: kelly k. Stem Cells. 2010 Dec;28(12):2129-40. doi: 10.1002/stem.538. Stem Cells. 2010. PMID: 20936707 Free PMC article.

5

Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.

Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K. Martin P, et al. Among authors: kelly k. Am J Pathol. 2011 Jul;179(1):422-35. doi: 10.1016/j.ajpath.2011.03.035. Epub 2011 May 13. Am J Pathol. 2011. PMID: 21703421 Free PMC article.

6

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.

Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K. Liu YN, et al. Among authors: kelly k. Oncogene. 2013 Jan 17;32(3):296-306. doi: 10.1038/onc.2012.58. Epub 2012 Feb 27. Oncogene. 2013. PMID: 22370643 Free PMC article.

7

Cediranib/AZD2171 inhibits bone and brain metastasis in a preclinical model of advanced prostate cancer.

Yin JJ, Zhang L, Munasinghe J, Linnoila RI, Kelly K. Yin JJ, et al. Among authors: kelly k. Cancer Res. 2010 Nov 1;70(21):8662-73. doi: 10.1158/0008-5472.CAN-10-1435. Epub 2010 Oct 19. Cancer Res. 2010. PMID: 20959486 Free PMC article.

8

LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.

Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, Goldsmith PK, Merino M, Kelly K. Ward Y, et al. Among authors: kelly k. Cancer Res. 2011 Dec 1;71(23):7301-11. doi: 10.1158/0008-5472.CAN-11-2381. Epub 2011 Oct 6. Cancer Res. 2011. PMID: 21978933 Free PMC article.

9

Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.

Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, Martin P, Kelly K. Liu YN, et al. Among authors: kelly k. Mol Cell Biol. 2012 Mar;32(5):941-53. doi: 10.1128/MCB.06306-11. Epub 2011 Dec 27. Mol Cell Biol. 2012. PMID: 22203039 Free PMC article.

10

Prostate cancer stem cells: The case for model systems.

Hynes PG, Kelly K. Hynes PG, et al. Among authors: kelly k. J Carcinog. 2012;11:6. doi: 10.4103/1477-3163.93701. Epub 2012 Mar 12. J Carcinog. 2012. PMID: 22529742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,722 results

Search Page

Filters